Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice

Clinical trial NCT04094051 · UNKNOWN

Trial details

NCT number: NCT04094051
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2019-10-01
Primary completion: 2020-12-31
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.